What to measure before starting a new treatment
The tests worth doing before starting a new treatment.
Writing on GLP-1s, peptides, dosing and metabolic health.
The tests worth doing before starting a new treatment.
On Friday I was at the Codes of Culture Summit in London. Most of the day was about luxury brands and fandom.
Your patient lost 8 pounds. You do not know if they lost muscle or fat. That is the problem with a monthly check in that only asks about weight. The number on the scale changed.
I want GLP-1s to be cheap. This year that started to happen. Novo Nordisk's main semaglutide patent ran out in India in March, and generic versions from several Indian drugmakers went on sale the...
The STEP 1 trial scanned 140 people with DEXA over 68 weeks. On semaglutide, body weight fell 15% and fat mass fell 19.3%, which is the part that gets talked about. Lean mass fell too, by 9.7%.
The fastest GLP-1 prescription path skips the one thing that should actually guide dosing: a baseline. Online pharmacies can dispense semaglutide after a questionnaire.
Your pharmacist fills 200 prescriptions a month. Your doctor sees the average from one trial. Neither of those facts alone tells you what dose you should be on. In the UK, pharmacists newly...
Fasting glucose misses the problem. Fasting insulin catches it years earlier.
The pharmacy counter is an underused point in preventive medicine, and in the UK it is about to get prescribing rights. Pharmacists newly registering from 2026 qualify as independent prescribers.
About half of the people who start a GLP-1 stop within a year. In Prime Therapeutics' US data on people taking one for obesity, only 1 in 12 were still on it at three years. I think those numbers...
The pharmacy is already the front door to metabolic health.
I see people on GLP-1s, on statins, on blood pressure meds. I almost never see their baseline first. That is not a criticism of the clinicians involved. It is just how the system was built.
GLP-1s broke the standard dose model. P4 medicine is how you fix it. You cannot run a fixed titration schedule on a molecule that behaves this differently across people and call that good...
"My fasting glucose always comes back normal. So why does my doctor want to do more testing?"
The link between blood sugar and mood is one of those things that's obvious once you see it, and almost invisible until you do. Casey Means lays it out in Good Energy: a rise in fasting glucose is...
The side effects that push people off GLP-1s are often not the drug's fault. They are a dosing problem. Standard titration starts at a fixed dose and roughly doubles every four weeks.
Before you start a GLP-1, get a DEXA scan first.
The hardest part of running a longevity clinic is getting patients to come back after the first visit. I opened my talk at Next Generation Longevity in Osaka on that point and heard versions of it...
Microdosing is doing a lot of work right now in the GLP-1 space. Too much. The way microdosing was originally described for GLP-1s, it means a fifth to a tenth of the standard starting dose.
The right GLP-1 dose has to be measured and personalised to the person taking it.
Showing 20 of 250 posts